NextCure, Inc. (NXTC)
USD 0.89
(-1.19%)
USD 0.89
(-1.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 22.37 Million | 6.34 Million | - |
| Cost of Revenue | 3.68 Million | 4.48 Million | 4.3 Million | 46.55 Thousand | 34.21 Thousand | 1.67 Million |
| Gross Profit | -3.68 Million | -4.48 Million | -4.3 Million | 22.33 Million | 6.31 Million | -1.67 Million |
| Operating Expenses | 67.63 Million | 75.9 Million | 70.76 Million | 63.6 Million | 43.82 Million | 23.19 Million |
| Selling, General and Administrative Expenses | 19.7 Million | 21.71 Million | 20.57 Million | 17.04 Million | 9.61 Million | 3.4 Million |
| Research and Development Expenses | 47.93 Million | 54.19 Million | 50.19 Million | 46.55 Million | 34.21 Million | 19.78 Million |
| Other Expenses | - | 1.17 Million | 1.37 Million | 4.62 Million | 3.74 Million | 397 Thousand |
| Cost and Expenses | 67.63 Million | 75.9 Million | 70.76 Million | 63.6 Million | 43.82 Million | 23.19 Million |
| Operating Income | -67.63 Million | -75.9 Million | -70.76 Million | -41.22 Million | -37.48 Million | -23.19 Million |
| Interest Expense | - | - | 77 Thousand | 183 Thousand | 209 Thousand | - |
| Income Tax Expense | - | -5.3 Million | 6.95 Million | -3.41 Million | 2.51 Million | 397 Thousand |
| Earnings before Tax | -62.72 Million | -74.73 Million | -69.38 Million | -36.6 Million | -33.73 Million | -22.79 Million |
| Net Income | -62.72 Million | -69.43 Million | -69.38 Million | -33.19 Million | -33.73 Million | -22.79 Million |
| Earnings Per Share Basic | -2.25 | -2.50 | -2.51 | -1.21 | -2.15 | -2.27 |
| Earnings Per Share Diluted | -2.25 | -2.50 | -2.51 | -1.21 | -2.15 | -2.27 |
| Weighted Average Shares Outstanding | 27.83 Million | 27.74 Million | 27.61 Million | 27.53 Million | 15.69 Million | 10.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.83 Million | 27.74 Million | 27.61 Million | 27.53 Million | 15.69 Million | 10.03 Million |
| Gross Margin | - | - | - | 1.00 | 0.99 | - |
| EBIT Margin | - | - | - | -1.84 | -5.48 | - |
| Profit Margin | - | - | - | -1.48 | -5.32 | - |
| EBITDA | -59.03 Million | -70.25 Million | -65.01 Million | -37.81 Million | -34.79 Million | -21.09 Million |
| Earnings Before Tax Margin | - | - | - | -1.84 | -5.91 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 6.28 Million | - | - | - |
| Cost of Revenue | 701 Thousand | 940 Thousand | 824 Thousand | 3.68 Million | 946 Thousand | 1.08 Million |
| Gross Profit | -701 Thousand | -940 Thousand | 5.46 Million | -3.68 Million | -946 Thousand | -1.08 Million |
| Operating Expenses | 15.79 Million | 14.82 Million | 14.96 Million | 63.95 Million | 15.61 Million | 19.15 Million |
| Selling, General and Administrative Expenses | 3.37 Million | 3.42 Million | 3.13 Million | - | 4.6 Million | 5.71 Million |
| Research and Development Expenses | 12.41 Million | 11.39 Million | 11.82 Million | - | 11.01 Million | 13.44 Million |
| Other Expenses | 1.09 Million | 1.19 Million | 1.32 Million | - | 1.31 Million | 1.29 Million |
| Cost and Expenses | 16.49 Million | 15.76 Million | 15.79 Million | 67.63 Million | 15.61 Million | 19.15 Million |
| Operating Income | -16.49 Million | -15.76 Million | -15.79 Million | -67.63 Million | -15.61 Million | -19.15 Million |
| Interest Expense | - | - | 975 Thousand | - | - | - |
| Income Tax Expense | - | 896.72 Thousand | 975 Thousand | - | 985.58 Thousand | 831.91 Thousand |
| Earnings before Tax | -15.4 Million | -17.1 Million | -14.46 Million | -62.72 Million | -14.3 Million | -17.85 Million |
| Net Income | -15.4 Million | -17.1 Million | -14.46 Million | -62.72 Million | -14.3 Million | -17.85 Million |
| Earnings Per Share Basic | -0.55 | -0.61 | -0.52 | - | -0.51 | -0.64 |
| Earnings Per Share Diluted | -0.55 | -0.61 | -0.52 | - | -0.51 | -0.64 |
| Weighted Average Shares Outstanding | 27.97 Million | 27.9 Million | 27.9 Million | 27.83 Million | 27.83 Million | 27.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.97 Million | 27.9 Million | 27.9 Million | 27.83 Million | 27.83 Million | 27.82 Million |
| Gross Margin | - | - | 0.87 | - | - | - |
| EBIT Margin | - | - | -2.38 | - | - | - |
| Profit Margin | - | - | -2.30 | - | - | - |
| EBITDA | -15.79 Million | -14.82 Million | -14.96 Million | - | -14.67 Million | -18.2 Million |
| Earnings Before Tax Margin | - | - | -2.51 | - | - | - |
ADRZF
0LSZ
009830
RAW
MYFW
ART